186 related articles for article (PubMed ID: 27852516)
1. Changes in the management of type 2 diabetic patients in family medicine practices in the Bursa region.
Göktaş O; Öz Gül Ö; Ertürk E
Prim Care Diabetes; 2017 Apr; 11(2):178-183. PubMed ID: 27852516
[TBL] [Abstract][Full Text] [Related]
2. Assessing variability in compliance with recommendations given by the International Diabetes Federation (IDF) for patients with type 2 diabetes in primary care using electronic records. The APNA study.
Brugos-Larumbe A; Aldaz-Herce P; Guillen-Grima F; Garjón-Parra FJ; Bartolomé-Resano FJ; Arizaleta-Beloqui MT; Pérez-Ciordia I; Fernández-Navascués AM; Lerena-Rivas MJ; Berjón-Reyero J; Jusué-Rípodas L; Aguinaga-Ontoso I
Prim Care Diabetes; 2018 Feb; 12(1):34-44. PubMed ID: 28732655
[TBL] [Abstract][Full Text] [Related]
3. Guidelines and clinical practice at the primary level of healthcare in patients with type 2 diabetes mellitus with and without kidney disease in five European countries.
Eder S; Leierer J; Kerschbaum J; Rosivall L; Wiecek A; de Zeeuw D; Mark PB; Heinze G; Rossing P; Heerspink HL; Mayer G
Diab Vasc Dis Res; 2019 Jan; 16(1):47-56. PubMed ID: 30238781
[TBL] [Abstract][Full Text] [Related]
4. Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis.
Filion KB; Joseph L; Boivin JF; Suissa S; Brophy JM
Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):973-6. PubMed ID: 19621344
[TBL] [Abstract][Full Text] [Related]
5. Patterns and trends in insulin intensification among patients with type 2 diabetes: a systematic review.
Polinski JM; Connolly JG; Curtis BH; Seeger JD; Gaskins K; Perez M; Smith BF; Shrank WH
Prim Care Diabetes; 2014 Jul; 8(2):101-9. PubMed ID: 24275103
[TBL] [Abstract][Full Text] [Related]
6. Approaches to treatment 1: How is type 2 diabetes actually treated?
Bloomgarden ZT
J Diabetes; 2015 Nov; 7(6):747-8. PubMed ID: 26211568
[No Abstract] [Full Text] [Related]
7. Optimal type 2 diabetes mellitus management: the randomised controlled OPTIMISE benchmarking study: baseline results from six European countries.
Hermans MP; Brotons C; Elisaf M; Michel G; Muls E; Nobels F;
Eur J Prev Cardiol; 2013 Dec; 20(6):1095-105. PubMed ID: 22605788
[TBL] [Abstract][Full Text] [Related]
8. Patterns of anti-diabetic medication use in patients with type 2 diabetes mellitus in England and Wales.
Datta-Nemdharry P; Thomson A; Beynon J; Donegan K
Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):127-135. PubMed ID: 27642000
[TBL] [Abstract][Full Text] [Related]
9. Changes in time to insulin initiation in type 2 diabetes patients: a retrospective database analysis in Germany and UK (2005-2010).
Kostev K; Rathmann W
Prim Care Diabetes; 2013 Oct; 7(3):229-33. PubMed ID: 23608219
[TBL] [Abstract][Full Text] [Related]
10. Adherence to national diabetes guidelines through monitoring quality indicators--A comparison of three types of care for the elderly with special emphasis on HbA1c.
Neumark AS; Brudin L; Neumark T
Prim Care Diabetes; 2015 Aug; 9(4):253-60. PubMed ID: 25865853
[TBL] [Abstract][Full Text] [Related]
11. Clinical coaching in primary care: Capable of improving control in patients with type 2 diabetes mellitus?
González-Guajardo EE; Salinas-Martínez AM; Botello-García A; Mathiew-Quiros Á
Prim Care Diabetes; 2016 Jun; 10(3):171-8. PubMed ID: 26615758
[TBL] [Abstract][Full Text] [Related]
12. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
[TBL] [Abstract][Full Text] [Related]
13. Improving type 2 diabetes mellitus glycaemic outcomes is possible without spending more on medication: Lessons from the UK National Diabetes Audit.
Heald AH; Livingston M; Malipatil N; Becher M; Craig J; Stedman M; Fryer AA
Diabetes Obes Metab; 2018 Jan; 20(1):185-194. PubMed ID: 28730750
[TBL] [Abstract][Full Text] [Related]
14. Achievement of recommended glucose and blood pressure targets in patients with type 2 diabetes and hypertension in clinical practice - study rationale and protocol of DIALOGUE.
Gitt AK; Schmieder RE; Duetting E; Bramlage P; Schneider S; Tschöpe D;
Cardiovasc Diabetol; 2012 Dec; 11():148. PubMed ID: 23216660
[TBL] [Abstract][Full Text] [Related]
15. Mismatch between ADA and AGS recommendations for glycated hemoglobin targets for older adults.
Tasci I; Safer U; Naharci I; Sonmez A
Prim Care Diabetes; 2018 Apr; 12(2):192-194. PubMed ID: 29396204
[TBL] [Abstract][Full Text] [Related]
16. Diabetes treatment in people with type 2 diabetes and schizophrenia: Retrospective primary care database analyses.
Rathmann W; Pscherer S; Konrad M; Kostev K
Prim Care Diabetes; 2016 Feb; 10(1):36-40. PubMed ID: 25937183
[TBL] [Abstract][Full Text] [Related]
17. Treatment Patterns in Patients With Newly Diagnosed Type 2 Diabetes in China: A Retrospective, Longitudinal Database Study.
Wang C; Gao Y; Zhu L; Huang M; Wu Y; Xuan J
Clin Ther; 2019 Aug; 41(8):1440-1452. PubMed ID: 31155146
[TBL] [Abstract][Full Text] [Related]
18. Regional differences in insulin therapy regimens in five European countries
.
Rathmann W; Czech M; Franek E; Kostev K
Int J Clin Pharmacol Ther; 2017 May; 55(5):403-408. PubMed ID: 28257286
[TBL] [Abstract][Full Text] [Related]
19. Employing observational method for prospective data collection: A case study for analyzing diagnostic process and evaluating efficacy of TCM treatments for diabetes mellitus.
Gu X; Huang N; Gu J; Joshi MK; Wang H
J Ethnopharmacol; 2016 Nov; 192():516-523. PubMed ID: 27616025
[TBL] [Abstract][Full Text] [Related]
20. Initial treatment of diabetes in Italy. A nationwide population-based study from of the ARNO Diabetes Observatory.
Bonora E; Cataudella S; Marchesini G; Miccoli R; Vaccaro O; Fadini GP; Martini N; Rossi E;
Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2661-2668. PubMed ID: 34218990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]